Here’s a story well worth checking out: ABC News recently looked at the pharmaceutical industry’s reluctance to pursue drugs specifically for treatment of childhood cancers. The central issue is that the numerous types of pediatric cancer mean there would be a small market for any single drug.

Subsequently, most of the pharmaceuticals used for cancer patients were developed for adults 30 or even 50 years ago. It was a chief concern of parents, doctors and activists who took part last week at the Second Annual Childhood Cancer Summit and meeting of the Congressional Pediatric Cancer Caucus.

"We are desperate for new treatments,” Dr. Peter Adamson of The Children's Hospital of Philadelphia told ABC News. “We have not had a single meaningful improvement in pediatric cancer medication in decades and the children have paid the price. Even though we cure four out of five pediatric cancer patients, even those who survive often go on to have lifelong side effects from the treatment we give them."